Biopharmatis to export CNS drugs to Hong Kong

Published: 2013-05-22 06:56:00

Updated: 2013-05-22 06:56:00

Biopharmatis, an affiliate of Hyundai Pharmaceutical Co., said Tuesday that it has signed an agreement with a new partner of Hong Kong to export Hyundai’s CNS (central nervous system)-related two medicines, Multapin tablets (mirtazapine) and Olapin tablets (olanzapine) for the next three years.

Under the deal, Biopharmatis will deliver the two drugs worth of $100,000 to Hong Kong, the Korean...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.